TLS data

Board of Directors

Meet the Board

Meet the Biocom Board of Directors, working to ensure Biocom's programs, initiatives, and strategies work to accelerate life science across California.


Executive Committee

Dan Burgess
Chair; Chairman, Nabriva Therapeutics, PLC
Dan Burgess
Carin Canale-Theakston
Vice Chair; CEO, Canale Communications
Canale Communications
Christophe Schilling, Ph.D.
Chair Elect; CEO, Genomatica, Inc.
Lisa Haile, J.D., Ph.D.
Vice President and General Counsel; Partner & Global Life Science Sector Chair, DLA Piper
DLA Piper
Richard Pascoe
Vice President, Industry; CEO, Apricus Biosciences
Apricus Biosciences, Inc.
Dan Kleeburg
Vice President, Finance; Partner, Ernst & Young LLP
Ernst & Young
Brent Jacobs
VP, Secretary; Executive Managing Director, Cushman & Wakefield Global Life Sciences Practice Group
Cushman & Wakefield
Ted Schroeder
Chair Emeritus; CEO, Nabriva Therapeutics
Nabriva Therapeutics
Joe Panetta
President & CEO, Biocom
Charles Dadswell
Sr. VP & General Counsel, Illumina
Illumina, Inc.
David Enloe
David Enloe, President and CEO of Ajinomoto Bio-Pharma Services
Ajinomoto Bio-Pharma Services
Stephen Ferruolo, J.D., Ph.D.
Dean & Professor of Law, USD School of Law
USD, University of San Diego
Wain Fishburn
Partner, Cooley
Wolfgang Glaesner, Ph.D.
CSO-AME, Eli Lilly & Company
Eli Lilly
James Levine
CEO, Sapphire Energy
Jack Lief
Director, CeleCor
Arena Pharmaceuticals
Steven Mento
President and CEO, Conatus Pharmaceuticals
Conatus Pharmaceuticals
Trindl Reeves
Principal, Marsh & McLennan Companies
Marsh & McLennan Agency LLC
Timothy Scott
CEO, TEGA Therapeutics
TEGA Therapeutics

Board of Directors

Steven Bartz, Ph.D.
Executive Director, Business Development and Licensing, West Coast, Merck Research Labs
Merck Research Laboratories
Rick Bregman
San Diego Market President and National Co-Head of Bank of America’s Healthcare Banking Group
Bank of America
Sandra Brown, Ph.D.
Vice Chancellor for Research, UCSD
Bruno Buisson, Ph.D.
CEO, Neuroservice
Jennifer Cayer
President & CEO, 3E Therapeutics
3E Therapeutics
Ho Cho, Ph.D.
Vice President, Biotherapeutics, Celgene
Taylor Crouch
President & CEO, Organovo
Nazeli Dertsakian
VP & General Manager of Product Operations, Genentech
John Dunn
General Counsel, Vital Therapies
Kelly Farrell
Chief of Staff, Sr. Director Oncology R&D, Pfizer
Pfizer Inc.
Michael Farrington
Vice President of Global Marketing, NuVasive
Oliver Fetzer, Ph.D.
CEO, Synthetic Genomics
Synthetic Genomics
Jack Florio
Managing Director, Objective Capital Partners
Brinson Patrick Securities
Gregory Frost, Ph.D.
CEO, F1 Bio Ventures
F1 Bio Ventures
Jeffrey W. Guise Ph.D. Esq.
Member, Wilson, Sonsini, Goodrich & Rosati
Wilson Sonsini Goodrich & Rosati
Ronnie Hanecak, Ph.D.
Senior Director, Licensing, UC Irvine Applied Innovations
UCI's Office of Research
Richard Heyman, Ph.D.
Executive Chairman, Metacrine
Aragon Pharmaceuticals
Guy Iannuzzi
CEO, Mentus
Gerald Joyce, M.D., Ph.D.
Institute Director, Genomics Institute of the Novartis Research Foundation
Genomics Institute of the Novartis Research Foundation
David Kabakoff, Ph.D.
Executive Partner, Private Equity, Sofinnova
Sofinnova Ventures
Katherine Kantardjieff, Ph.D.
Dean, College of Science and Mathematics, California State University San Marcos
California State University of San Marcos
Steve Kay, Ph.D.
Provost Professor of Neurology, Biomedical Engineering and Biological Sciences Director of Convergent Bioscience, USC
USC Stevens Center for Innovation
Paul Laikind, Ph.D.
President & CEO, ViaCyte
Cheston Larson
Partner & Co-Chair – Life Sciences Industry Group, Latham & Watkins LLP
Latham & Watkins
James Mackay, Ph.D.
CEO, Aristea Therapeutics
Ardea Biosciences
Damien McDevitt
Chief Business Officer
Ionis Pharmaceuticals
Marc T. Morley
Member, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo
Tracy Murphy
Executive Vice President, Life Science, Kilroy Realty
Kilroy Realty Corporation
Steve Pacelli
EVP, Strategy & Corporate Affairs, DexCom
Dexcom, Inc.
Kenneth Polin
Partner, Jones Day
Jones Day
Daniel J. Ryan
Executive Vice President, Alexandria Real Estate Equities
Alexandria Real Estate Equities
Dean Samsvick
Partner, KPMG LLP
Peter Silvester
Senior Vice President, President of Life Sciences Solutions, Thermo Fisher Scientific
Thermo Fisher Scientific
Lesley Stolz, Ph.D.
Head, JLABS California
Johnson & Johnson Innovation, JLABS
Tsuneo Takahashi
President, NF Corporation
NF Techno Commerce
Kevin Tremblay
Sr. Director, SD Market Leader, Biomed Realty
Biomed Realty Trust
David Weitz
Head of Takeda California and Global Research Externalization, Takeda California, Inc.
Takeda Pharmaceuticals U.S.A., Inc.
Ken Weixel
Managing Partner, San Diego, Deloitte & Touche LLP
Stephen Welter
Vice President of Research, SDSU
SDSU, Graduate & Research Affairs
Tom West
Division President, Diagnostic Solutions, Hologic

Life Directors

Ken Baldwin
Principal, Ferguson Pape Baldwin Architects
Ferguson Pape Baldwin Architects
David Hale
Chairman, Hale BioPharma Ventures
Hale Biopharma Ventures
Brent Jacobs
VP, Secretary; Executive Managing Director, Cushman & Wakefield Global Life Sciences Practice Group
Cushman & Wakefield
Magda Marquet, Ph.D.
Co-Chairman & Founder, Althea (a member of Ajinomoto Group)
Ajinomoto Bio-Pharma Services
Tina Nova, Ph.D.
President and CEO, Molecular Stethoscope
Molecular Stethoscope
Larry Stambaugh
Chairman, Molecular Assemblies, Inc.
Molecular Assemblies


Mark Cafferty
President & CEO, SD Regional Economic Development Corp.
San Diego Regional Economic Development Corp.
Peter Callstrom
President & CEO, SD Workforce Partnership
San Diego Workforce Partnership
Sunita Cooke, Ph.D.
Superintendent/President, Mira Costa College
Mira Costa College
Scott Lippman, Ph.D.
Director, UCSD Moores Cancer Center
Moores Cancer Center, Ucsd
Greg McKee
President & CEO
Peter Preuss
President, The Preuss Foundation
Peter Preuss
Jerry Sanders
President & CEO, SD Regional Chamber of Commerce
San Diego Regional Chamber of Commerce
David Webb, Ph.D.
Adjunct Professor, Scripps Research Institute
Scripps Research